BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 7, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for Feb. 19, 2025

Feb. 19, 2025
New hires and promotions in the biopharma industry, including: Atomwise, Biosion, Cidara, Ona, Orphai, Pheast, Reflexion Medical, Ventus.
Read More

Appointments and advancements for Feb. 19, 2025

Feb. 19, 2025
New hires and promotions in the med-tech industry, including: Kestra Medical Technologies, Lifeward, Saladax Biomedical, Vicarious Surgical.
Read More

Appointments and advancements for Feb. 18, 2025

Feb. 18, 2025
New hires and promotions in the biopharma industry, including: Entero, Inhibikase, Loqus23, Nuclera, Nura, Olema, Zymeworks.
Read More

Appointments and advancements for Feb. 14, 2025

Feb. 14, 2025
New hires and promotions in the med-tech industry, including: Augere.
Read More

Appointments and advancements for Feb. 13, 2025

Feb. 13, 2025
New hires and promotions in the biopharma industry, including: Augustine, Cytovation, Neumora, Octavian, Serina.
Read More

Appointments and advancements for Feb. 13, 2025

Feb. 13, 2025
New hires and promotions in the med-tech industry, including: Epitel, Forsight Robotics, Precision Cardiovascular.
Read More

Appointments and advancements for Feb. 12, 2025

Feb. 12, 2025
New hires and promotions in the biopharma industry, including: AI Proteins, Altpep, Ampersand, Bluejay, Cognito, Kala, Lakewood-Amedex, Lycia Orchard.
Read More

Appointments and advancements for Feb. 12, 2025

Feb. 12, 2025
New hires and promotions in the med-tech industry, including: Breg, Corvista, Medicover.
Read More

Appointments and advancements for Feb. 11, 2025

Feb. 11, 2025
New hires and promotions in the biopharma industry, including: Aro, Glox, LB.
Read More

Appointments and advancements for February 11, 2025

Feb. 11, 2025
New hires and promotions in the med-tech industry, including: 3Daughters, Covarsa Dx, Cytokinetics, LRS Healthcare, Solera, Stryker.
Read More
Previous 1 2 … 57 58 59 60 61 62 63 64 65 … 327 328 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 6, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Illustration of brain and brain waves, concept of focal seizure

    Hyperexcitability may be joint problem in epilepsy, dementia

    BioWorld
    The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads

    BioWorld
    Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing